Contracts & Grants

Information is courtesy of the Office of Sponsored Projects. Each listing includes the faculty member's name and school(s) appointments at The University of Texas Health Science Center at Houston, project title, contracting or granting agency, and funding amount.

New

H. Vernon Anderson, Medical School (MS), DES-Cover Registry, Cordis Corporation, $15,165.

Ananth Annapragada, School of Health Information Sciences (SHIS), Automodulated Pulmonary Drug Delivery, Whitaker Foundation, $79,158.

Jaroslaw Aronowski, MS and Graduate School of Biomedical Sciences (GSBS), Velcade (PS-341) A Proteasome Inhibitor, Treatment for Intracerebral Hemorrhage, Millenium Pharmaceuticals, $40,020.

Jose Bayona, MS, Physician Uncertainty Reduction for Hypertension Control, Baylor College of Medicine, $15,989.

Rebecca G. Girardet, MS, Photodocumentation in Cases of Child Abuse and Neglect, Memorial Hermann Children's Hospital, $2,086.

James C. Grotta, MS, Phase 2B Study of TNK in Acute Stroke, University of Virginia, $131,794; and Microbubble-Enhanced Clotbust Treatment of Acute Ischemic Stroke, Imarx Therapeutics, $148,941.

Adelaide A. Hebert, MS, An Adrenal Suppression Study of Clobetasol Propionate Lotion, 0.05% (Clobex Topical Lotion) in Subjects with Plaque-Type Psoriasis, Galderma Research & Development, $48,425.

Gloria P. Heresi, MS, The Non-Resource Patient Fund, Children Affected by AIDS Foundation, $9,200.

Keith Hoots, MS, Hemophilia and Thrombosis Research Society Registry, Hemophilia and Thrombosis Research Society, $14,000.

Madurai Sriram Iyengar, SHIS, Medical Informatics and Healthcare Systems Evidence-Based Medicine and Medical Informatics, National Space Biomedical Research Institute, $89,037.

Philip C. Johnson, MS, A Phase 2, Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Three-Arm Study of the Anti- CD4 Monoclonal Antibody TN-355 with Optimized Background Therapy in Treatment-Experienced Subjects Infected with HIV-1, Tanox Inc., $97,128.

Susan Landry, MS, Preschool Curriculum Evaluation Research Grant Program, Research Triangle Institute, $8,684.

Hope Northrup, MS and GSBS, Camp PHEVER (State-Wide Camp for Children with Phenylketonuria Held at Camp For All), Memorial Hermann Children's Hospital, $9,600.

Takuya Ogawa, Dental Branch (DB), Molecular Studies on the Transactivation Potential of PAX9, National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research, $148,500.

Sudhir Paul, MS and GSBS, Covalent Tolerance Induction to Factor VIII, Hemophilia Association of New York, $250,000.

Ronald Portman, MS, Assessment of Vascular Function in Hypertensive Children, NIH, National Heart, Lung and Blood Institute, $111,804.

Eyal E. Porat, MS, A Comparative Evaluation of Human Thrombin Versus Bovine Thrombin in Achieving Hemostasis in Patients Undergoing Cardiovascular, Neurologic (Spine) and General Surgery Procedures, Ethicon Inc., $40,300.

John M. Powers, DB and GSBS, Mechanical Properties of Access Stuffcoat, Centrix Inc., $4,800; Bond Strength of New Adhesive to Dentin with Supercure and Encore Rapid Composite, Centrix Inc., $1,600.

David J. Robinson, MS, A Multicenter, Randomized, Double-Blind Study Comparing the Clinical Effects of Intravenous Montelukast with Placebo in Patients with Acute Asthma, Merck & Co. Inc., $38,311.

Alan C. Swann, MS and GSBS, Norepinephrine and Impulsivity, NIH, National Institute of Mental Health, $1,578,257; A 52-Week, Open Label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine 750-2500 Mg/D in the Treatment of Manic Episodes in Bipolar I Disorder, Novartis Pharmaceuticals Corp., $83,736; and A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Tolerability of Licarbazepine 1000-2500 Mg/D in the Treatment of Manic Episodes of Bipolar I Disorder Over 3 Weeks, Novartis Pharmaceuticals Corp., $280,254.

Paul R. Swank, MS, Neurobehavioral Outcome of Head Injury in Children, Baylor College of Medicine, $43,266.

Patrick M. Tarwater, School of Public Health, Viral Host Interactions in SIV Cardiac Dysfunction, Johns Hopkins University, $14,939; and CNS Mechanisms of MCP1 Transcription, Johns Hopkins University, $9,959.

John F. Teichgraeber, MS, Texas Cleft and Craniofacial Team, Memorial Hermann Children's Hospital, $89,724.

M. Neal Waxham, MS and GSBS, Memory Mechanisms: Modifiability and Stability, Brandeis University, $99,455.

Mark L.Williams, SPH, Tanzanian Injection Drug Use/HIV Prevention Project, NIH, National Institute on Drug Abuse, $358,004.

Renewal

Bruce C. Kone, MS and GSBS, Ryan White Title 1 Formula (Department of Health and Human Services) Outpatient Ambulatory Grants (T5), Harris County Hospital District, $256,388.

Jon E. Tyson, MS, High-Risk Infant Clinic, Memorial Hermann Children's Hospital, $140,000.

Edgar T.Walters, MS and GSBS, Nociceptive Memory: Mechanisms of Hyperexcitability (Old) Primitive Foundations of Neuropathic Hyperalgesia, NIH, National Institute of Neurological Disorders and Stroke, $1,688,548.